(ATHN) Athenahealth IPO priced at $18, above the $14 to $16 range.
(BCRX) BioCryst Pharma shares down over 30% after flu studies failed to show significant improvements.
(BRLC) Syntax-Brillian announced it has already named a CFO replacement.
(BSC) Bear Stearns reporting earnings.
(CAG) ConAgra $0.34 EPS vs $0.29 est.
(CBRL) CBRL group boosted dividend and approved 1 million shares for a buyback plan.
(COT) Cott lowered guidance.
(CRA) Celera announced a $33 million acquisition of Atria Genetics.
(FDX) FedEx $1.58 EPS vs $1.54 est.; sees next quarter $1.60 to $1.75 vs. $1.97 est.; Sees fiscal year $6.70 to $7.10 vs. $7.19 estimate (4% lower).
(GS) Goldman Sachs trading up over 1% after earnings posted at $6.13 (on items);noted gain in mortgage shorts, but major loan losses.
(IMCL) ImClone Systems announced that National Cancer Institute has selected 10 of its proposals for Phase I/II trials of its monoclonal antibody.
(ISIS) ISIS Pharma announces $4.2 million in Government contracts awarded for biodefense applications development.
(LKQX) LKQ announced its 12 million share secondary offering priced at $31.00 per share.
(MHGC) Morgans Hotel Group announced the resignation of its CEO.
(MNRO) Monroe Muffler lowered guidance.
(NDAQ) NASDAQ acquired OMX; selling 28% LSE stake to Borse Dubai..
(NTCT) NetScout slightly raised guidance.
(PIR) Pier 1 Imports -$0.49 EPS vs -$0.44 est.
(PKE) Park Electrochem $0.42 EPS vs $0.29 est.
(PRGS) Progress Software $0.44 EPS vs $0.44 est.; guides next quarter $0.51 to $0.53 vs $0.52 estimate.
(SCHL) Scholastic Corp. -$0.07 vs -$0.47 estimate; unsure if comparable.
(SLM) SLM purchase is in jeopardy according to New York Times; like that wasn’t known.
(SNE) Sony delayed virtual world service ‘Home" for PS3.
(T) AT&T is Cramer’s growth and dividend stock he liked last night and interviewed the CFO.
Jon C. Ogg
September 20, 2007